Table 2 Factors associated with Mpox knowledge levels among healthcare workers (N=399).
n (%) | Total (N=399) | Good (n=150) | Poor (n=249) | p-value |
|---|---|---|---|---|
Sex | 0.774 | |||
Female | 327 | 124 (37.9%) | 203 (62.1%) | |
Male | 72 | 26 (36.1%) | 46 (63.9%) | |
Age Category, years | 0.994 | |||
21–35 | 217 | 82 (37.8%) | 135 (62.2%) | |
36–50 | 171 | 64 (37.4%) | 107 (62.6%) | |
>50 | 11 | 4 (36.4%) | 7 (63.6%) | |
Marital status | 0.510 | |||
Married | 289 | 105 (36.3%) | 184 (63.7%) | |
Single | 89 | 38 (42.7%) | 51 (57.3%) | |
Divorced/widow | 21 | 7 (33.3%) | 14 (66.7%) | |
Position | 0.739 | |||
Pharmacist | 274 | 102 (37.2%) | 172 (62.8%) | |
Physician | 95 | 34 (35.8%) | 61 (64.2%) | |
Nurse | 23 | 11 (47.8%) | 12 (52.2%) | |
Dentist | 7 | 3 (42.9%) | 4 (57.1%) | |
Level of work | 0.066 | |||
Specialist | 182 | 60 (33.0%) | 122 (67.0%) | |
General Practitioner | 146 | 67 (45.9%) | 79 (54.1%) | |
Consultant | 53 | 16 (30.2%) | 37 (69.8%) | |
Residents | 18 | 7 (38.9%) | 11 (61.1%) | |
Medical experience, years | 0.005* | |||
Less than one year | 27 | 16 (59.3%) | 11 (40.7%) | |
1–5 years | 79 | 37 (46.8%) | 42 (53.2%) | |
More than five years | 293 | 97 (33.1%) | 196 (66.9%) | |
Region | 0.201 | |||
Delta region | 231 | 98 (42.4%) | 133 (57.6%) | |
Alexandria region | 76 | 25 (32.9%) | 51 (67.1%) | |
Great Cairo region | 70 | 21 (30.0%) | 49 (70.0%) | |
Canal Region | 13 | 3 (23.1%) | 10 (76.9%) | |
Upper Egypt | 9 | 3 (33.3%) | 6 (66.7%) | |
Mpox medical education | <0.001* | |||
No | 215 | 62 (28.8%) | 153 (71.2%) | |
Yes | 184 | 88 (47.8%) | 96 (52.2%) | |
Heard about Mpox before | 0.743 | |||
No | 67 | 24 (35.8%) | 43 (64.2%) | |
Yes | 332 | 126 (38.0%) | 206 (62.0%) | |
First time knowing Mpox | 0.166 | |||
I didn’t hear about it | 27 | 13 (48.1%) | 14 (51.9%) | |
Within several days or weeks ago | 57 | 26 (45.6%) | 31 (54.4%) | |
aWithin the last month or later | 315 | 111 (35.2%) | 204 (64.8%) | |
